Multiple indirect cellular pathways

Multiple indirect cellular pathways is a descriptive term used to characterize drugs or substances that exert their therapeutic effects through a variety of downstream biological processes rather than by binding to a single, specific molecular target. This classification is often applied to complex mixtures, such as botanical extracts, or to drugs whose primary molecular mechanism remains poorly defined despite clear physiological activity (ChEMBL Database, 2024). Because this term encompasses a broad range of interactions across different signaling cascades, metabolic routes, and cellular responses, it does not represent a discrete therapeutic target in the traditional sense. In pharmacological databases, such entries serve as placeholders for compounds with pleiotropic effects or uncharacterized modes of action (Nature Reviews Drug Discovery, 2021). From a drug development perspective, this classification indicates a lack of mechanistic specificity, which can complicate the optimization of lead compounds and the prediction of potential side effects. Consequently, it is generally treated as an incorrect or placeholder target entry in structured bioinformatics datasets as it lacks a specific gene or protein association.

Other names

Indirect cellular pathwaysMultiple pathwaysNon-specific cellular mechanismsPleiotropic cellular effects

Indirect modulation of various cellular signaling and metabolic pathways rather than interaction with a specific molecular target.